Back
Sarepta Therapeutics Stock Price Chart
Sponsored
"Hedge Fund King's" $1 billion bet (Why many are following suit)
See important Reg A disclosures: Masterworks.com/cd
Sell
40
SRPT
Sarepta Therapeutics
Last Price:
125.95
Seasonality Move:
20.52%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
Ready For A Once In A Generation Opportunity In The Copper Space?
Click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 143.85 | Sell |
| 20-day SMA: | 138.89 | Sell |
| 50-day SMA: | 129.34 | Sell |
| 200-day SMA: | 109.56 | Buy |
| 8-day EMA: | 141.14 | Sell |
| 20-day EMA: | 139.05 | Sell |
| 50-day EMA: | 131.95 | Sell |
| 200-day EMA: | 113.67 | Buy |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.04 | Buy |
| Relative Strength Index (14 RSI): | 38.87 | Sell |
| Chaikin Money Flow: | 2960197 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (121.41 - 149.43) | Sell |
| Bollinger Bands (100): | (111.47 - 135.21) | Sell |
Sarepta Therapeutics Technical Analysis
| Mar-6 | Mar-7 | Mar-8 | Mar-9 | Mar-10 | Mar-13 | Mar-14 | Mar-15 | Mar-16 | Mar-17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 122.69 while SRPT 8-day simple moving average is 143.85, which is a Sell signal.
- The stock price of SRPT is 122.69 while Sarepta Therapeutics 20-day SMA is 138.89, which makes it a Sell.
- Sarepta Therapeutics 50-day simple moving average is 129.34 while SRPT share price is 122.69, making it a Sell technically.
- SRPT stock price is 122.69 and Sarepta Therapeutics 200-day simple moving average is 109.56, creating a Buy signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
40
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Sell
The current Sarepta Therapeutics [SRPT] share price is $122.69. The Score for SRPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
10.79B
Price in USD:
122.69
Share Volume:
7.41M
Sarepta Therapeutics 52-Week Range
52-Week High:
159.84
52-Week Low:
61.28
Sell
40
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?
The Sarepta Therapeutics stock price is 122.69 USD today. -
Will SRPT stock go up or go down?
Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sarepta Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 122.69 while SRPT 8-day exponential moving average is 141.14, which is a Sell signal.
- The stock price of SRPT is 122.69 while Sarepta Therapeutics 20-day EMA is 139.05, which makes it a Sell.
- Sarepta Therapeutics 50-day exponential moving average is 131.95 while SRPT share price is 122.69, making it a Sell technically.
- SRPT stock price is 122.69 and Sarepta Therapeutics 200-day simple moving average is 113.67, creating a Buy signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.47 per share, and an increase next year of $9.40 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
- SRPT Moving Average Covergence Divergence (MACD) indicator is 4.04, suggesting Sarepta Therapeutics is a Buy
- Sarepta Therapeutics Relative Strength Index (RSI) is 38.87, which suggest Sarepta Therapeutics is oversold
- The Bollinger Bands (25) for Sarepta Therapeutics is (121.41 - 149.43), which suggest Sarepta Therapeutics is a Sell
- The Bollinger Bands (100) for Sarepta Therapeutics is (111.47 - 135.21), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.